ROCKWELL MEDICAL, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ROCKWELL MEDICAL, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $13.72M.
- ROCKWELL MEDICAL, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $1.00K.
- ROCKWELL MEDICAL, INC. stock issued during period, value, conversion of convertible securities for fiscal 2014 was $8.43M, a 623.90% increase from fiscal 2013.
- ROCKWELL MEDICAL, INC. stock issued during period, value, conversion of convertible securities for fiscal 2013 was $1.16M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-09-30 | $13.72M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.00K 10-Q · filed 2023-11-14 | |
| 2014-12-31 | $8.43M 10-K · filed 2017-03-15 | |
| 2013-12-31 | $1.16M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |